Why the study?
Does high-dose hydrochlorothiazide (450 mg/day) improve blood pressure lowering compared to 150 mg/day in hypertensive outpatients?
Does high-dose hydrochlorothiazide (450 mg/day) improve blood pressure lowering compared to 150 mg/day in hypertensive outpatients?
Increasing hydrochlorothiazide doses beyond standard maximal diuretic levels (from 150 mg to 450 mg daily) provides no additional antihypertensive benefit.
High-dose HCT yields no added BP reduction; hypothesis-generating and should not change practice without RCTs.
The ceiling diuretic dose of hydrochlorothiazide (HCT) is 200 mg. per day. To investigate the antihypertensive effect of doses of HCT greater than that producing maximal diuresis, 21 hypertensive outpatients were studied. These patients were selected from a large group and included only those who, on previous occasions, had failed to obtain adequate blood pressure control from diuretic therapy alone. After stabilization on placebo, all patients received HCT 150 mg. per day for 12 weeks. The dose was increased to 450 mg. per day in the 19 patients whose hypertension was inadequately controlled on the lower dose, and they were followed for a further 20 weeks. At regular intervals, measurements were made of biochemical and hematologic indices as well as serum magnesium and HCT concentration. Despite doubling of serum HCT concentration with the higher dose, the patients had no greater blood pressure lowering and no changes in biochemical measurements when the dose of HCT was tripled.
No takes yet. Share an insight, caveat, or question.
McLeod et al. (1970) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: